Moderna Inc (MRNA)

Data from FactSet shows that with only 20% of S&P 500 companies having reported first quarter results, 79% have announced better than expected earnings per share (EPS), while 69% have reported better revenue than Wall Street had forecast.

MRNA Stock Alert: 11 Things to Know as Moderna Seeks FDA Vaccine Approval for Kids

By William White, InvestorPlace Writer Apr 28, 2022

Moderna (MRNA) stock could get a boost after the company revealed an application with the FDA for its Covid-19 vaccine in kids.

7 Top-Rated Biotech Stocks to Buy for Q2

By Louis Navellier and the InvestorPlace Research Staff Apr 21, 2022

In these tumultous economic times, look to sectors that are outside the turmoil. Each of these seven biotech stocks fit the bill.

3 Hot Stocks That Could Be Set for a Cold Shower

By Tezcan Gecgil, InvestorPlace Contributor Apr 18, 2022

Rising inflation, high energy prices and geopolitical turmoil have become this year's dominating themes. Here are three hot stocks that could see declines in the rest of the year.

Moderna May Have Put Its Best Days Behind It

By Chris Markoch, InvestorPlace Contributor Apr 14, 2022

MRNA stock is up 11% in the last 30 days. However, for many reasons, the stock may face resistance as it tries to move higher.

Moderna’s Lot Recall Is a Blot Despite Its Recent 2nd Covid-19 Booster Approval

By Mark R. Hake, CFA Apr 11, 2022

MRNA stock could get hurt from a recent recall in Moderna's Covid-19 vaccine, despite other recent good news from an EUA approval.

Concerns About Moderna Stock’s Future Are Overdone

By Louis Navellier and the InvestorPlace Research Staff Apr 7, 2022

MRNA stock may come back into favor once the market realizes it has overreacted to news of slackening demand for Covid-19 vaccines.

Annual Boosters Might Not Give Moderna the Boost It Needs

By Thomas Niel, InvestorPlace Contributor Apr 5, 2022

Stay Away from MRNA stock, until it either falls to a price where it's arguably a bargain, or if it makes progress bringing non-coronavirus vaccines to market.

3 Vaccine Stocks to Buy on the New Covid Variant Surge

By Faisal Humayun, InvestorPlace Contributor Mar 31, 2022

These vaccine stocks are likely to trend higher with the recent surge in covid-19 cases and concerns related to a new variant.

3 Blue-Chip Stocks to Buy That Are Still Oversold

By Chris Tyler, InvestorPlace Contributor Mar 30, 2022

These badly beaten blue-chip stocks still hold strong long-term potential. Here's how you can best advantage the current rally in blue-chips.

MRNA Stock: What’s Going on With Moderna This Week?

By William White, InvestorPlace Writer Mar 30, 2022

Moderna (MRNA) stock is on the move this week after the CDC and the FDA updated their Covid-19 booster shot recommendations.

Investors Seek Second Act with Moderna Stock

By Dana Blankenhorn, InvestorPlace Contributor Mar 29, 2022

Moderna hopes its combination vaccine for COVID and the flu can keep profits high but investors are skeptical. MRNA stock struck gold with its Covid-19 vaccine but investors want to know if there are any other blockbusters in its pipeline.